MC2 Therapeutics A/S
CVR 29526346 · Public limited company (A/S) · Active · High risk
MC2 Therapeutics A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 3.0% over the next 12 months, which is 2.1 times the average for Danish companies. 20 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -224.5m and a net result of DKK -7.8m. CEO: Trine Ahlgreen.
Bankruptcy risk for MC2 Therapeutics A/S
2.1 × the average (1.41%) · higher risk than 88% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 29526346
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (20 years)
- Address
- Agern Alle 24
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Frisørsaloner - Share capital
- DKK 6.6m
- Employees
- 10 (2018)
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 20 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -398.3% |
| Current ratio | 99% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 74 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 22.2m | DKK 24.5m | DKK 26.4m |
| Net profit | DKK -7.8m | DKK -53.0m | DKK -41.9m |
| Equity | DKK -224.5m | DKK -218.4m | DKK -164.5m |
| Total assets | DKK 56.4m | DKK 64.4m | DKK 30.6m |
| Cash | DKK 1.9m | DKK 7.1m | – |
| Short-term debt | DKK 32.6m | DKK 12.6m | – |
| Avg. employees | 11 | 15 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 183 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 190 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 198 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 1 Jan 2020 – 31 Dec 2020 | 182 | ||
| 1 Jan 2019 – 31 Dec 2019 | 231 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 157 | ||
| 1 Jan 2017 – 31 Dec 2017 | 164 | ||
| 1 Jan 2016 – 31 Dec 2016 | 109 | ||
| 1 Jan 2015 – 31 Dec 2015 | 155 | ||
| 1 Jan 2014 – 31 Dec 2014 | 139 | ||
| 1 Jan 2013 – 31 Dec 2013 | 57 | ||
| 1 Jan 2012 – 31 Dec 2012 | 151 | ||
| 1 Jan 2011 – 31 Dec 2011 | 143 | ||
| 1 Jan 2010 – 31 Dec 2010 | 151 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 158 | ||
| 1 Jan 2007 – 31 Dec 2007 | 161 | ||
| 4 May 2006 – 31 Dec 2006 | 158 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Trine Ahlgreen | Current | |
| CEO | Steen Sindet-Pedersen | ||
| CEO | Anette Merete Nøhr Clausen | ||
| CEO | Jesper Jørn Lange | ||
| Board | Mads Jørgen Nøhr Clausen | Current | |
| Board | Anders Dahlgaard Hove | Current | |
| Board | Tomas Dahl Mikkelsen | Current | |
| Board | John Sørensen Haurum | Current | |
| Board | Jesper Jørn Lange | ||
| Board | Mette Vagner Johannesen | ||
| Board | Paul Louis Berns | ||
| Owner (15%) | MC2 HOLDING ApS | Current | |
| Owner (33%) | Selskabet af 4. april 2023 ApS | Current | |
| Owner (33%) | Alsmark Invest II ApS | Current | |
| Owner (25%) | MC2 HOLDING ApS | ||
| Owner (15%) | INVESTERINGSSELSKABET AF 30.4.1992 ApS | ||
| Owner (33%) | ALSMARK INVEST II ApS | ||
| Owner (5%) | LANC ApS | ||
| Owner (20%) | MC2 HOLDING ApS | ||
| Owner (20%) | INVESTERINGSSELSKABET AF 30.4.1992 ApS | ||
| Owner (33%) | November S.á.r.l. | ||
| Owner (15%) | FÆLLES INVEST 2 A/S | ||
| Owner (10%) | INVESTERINGSSELSKABET AF 30.4.1992 ApS | ||
| Owner (15%) | INVESTERINGSSELSKABET AF 30.4.1992 ApS | ||
| Owner (10%) | FÆLLES INVEST 2 A/S | ||
| Owner (20%) | INVESTERINGSSELSKABET AF 30.4.1992 ApS | ||
| Owner (33%) | INVESTERINGSSELSKABET AF 30.4.1992 ApS | ||
| Owner (33%) | HOLDINGSELSKABET J.S.R. AF 1.11.83 ApS | ||
| Owner (33%) | HOLDINGSELSKABET J.S.R. AF 1.11.83 ApS | ||
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Jesper Jørn Lange | Current |
The CEOs' other companies
Trine Ahlgreen – 2 other companies
- ZADEC ApS Active
- biomee ApS Active
Steen Sindet-Pedersen – 9 other companies, of which 2 bankrupt
- STEEN SINDET-PEDERSEN ApS Bankrupt 23 Nov 2011
- STEENO RESEARCH GROUP A/S Bankrupt 15 Dec 2005
- DENDRIT HOLDING ApS Opløst
- DRUGMODE ApS Fusioneret
- FEPPE ApS Compulsorily dissolved
- PRIDE PROTEOMICS A/S Fusioneret
- Renovaro Biosciences Denmark ApS Active
- ZADEC ApS Active
- ZADEC HOLDING ApS Fusioneret
Anette Merete Nøhr Clausen – 16 other companies, of which 1 bankrupt
- DANISH CARBIDE TOOLS A/S Bankrupt 14 Jul 2006
- A/S AF 22.6.1993 I Opløst
- ANC HOLDING ApS Active
- Alsmark Invest II ApS Active
- ApS AF 22.6.1993 II Opløst
- ApS KBIL 38 NR. 1481 Compulsorily dissolved
- D-ICE A/S Fusioneret
- DALSGAARD NIELSEN ApS Fusioneret
- DANFOSS HISTORICAL CENTER A/S Active
- DRUGMODE ApS Fusioneret
- INDUSTRIAL SOFTWARE ApS Opløst
- PRIDE PROTEOMICS A/S Fusioneret
- TAKS A/S Compulsorily dissolved
- Udviklingsselskabet af 27. oktober 2015 ApS Active
- ZADEC ApS Active
- ZADEC HOLDING ApS Fusioneret
Jesper Jørn Lange – 13 other companies
- DRUGMODE ApS Fusioneret
- JØRN V. LANGE A/S Opløst
- LANC ApS Active
- LASCH HOLDING ApS Active
- MARIA GRAMS EFTF. ApS Fusioneret
- MC2 BIOACTIVE ApS Fusioneret
- PRIDE PROTEOMICS A/S Fusioneret
- TEE CEE HOLDING A/S Opløst
- TOXICELL ApS Opløst
- ViaContext ApS Active
- ZADEC ApS Active
- ZADEC HOLDING ApS Fusioneret
- biomee ApS Active
Address history (3 moves)
| Agern Alle 24, 2970 Hørsholm | |
| Bøge Alle 5, 2970 Hørsholm | |
| Tuborg Havnevej 19, 2900 Hellerup | |
| c/o Rønne & Lundgren Advokatfirma, Tuborg Havnevej 18, 2900 Hellerup |
Former names
| MC2 Therapeutics A/S | – now |
| MC2 Therapeutics ApS | – |
| MC2 BIOTEK ApS | – |
| BIOTECH AF 4. MAJ 2006 ApS | – |
Employees per year
Other companies at the same address
- AVS 07.02.2022 ApS Bankrupt
- Agger Electronic Holding ApS Bankrupt
- Agmondo ApS Bankrupt
- Datoselskabet af 29. august 2024 ApS Bankrupt
- Dinnr ApS Bankrupt
- Euronome Analyzer ApS Bankrupt
- ID2ME A/S Bankrupt
- Kube8 ApS Bankrupt
- SAFESONE HOLDING A/S Bankrupt
- Safesone ApS Bankrupt
- UDVIKLINGSSELSKABET OP2013 ApS Bankrupt
- ACRONORDIC ApS Active
- ALO Patents ApS Active
- ALTOO ApS Active
- Alsted Innovation ApS Active
- Asergo ApS Active
- Asergo Holding ApS Active
- Breye Therapeutics ApS Active
- CLARA INVEST ApS Active
- COLDING CONSULT ApS Active
- CPC - CENTER FOR PRODUCT CUSTOMIZATION ApS Active
- CROXX MED ApS Active
- Central Park Boathouse ApS Active
- Convenience Group ApS Fusioneret
- DALL ENERGY ApS Active
Similar companies in Rudersdal
- PA BY LIEBERKIND ApS Holte
- Tiny Dogs ApS Holte
- Showcom.eu ApS Nærum
- LEADERBOARD MANAGEMENT ApS Holte
- LAU LAURITZEN FILM ApS Nærum
- AMADEUS SECURITIES A/S Holte
- INTERCASTING HOLDING ApS Nærum
- PJB HOLDING ApS Vedbæk
- NETCHOICE ApS Nærum
- NETVISION A/S Vedbæk
- HAMMERSTAD HOLDING ApS Holte
- ApS KBUS 35 NR. 1080 Holte
Questions and answers about MC2 Therapeutics A/S
Has MC2 Therapeutics A/S gone bankrupt?
No, MC2 Therapeutics A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MC2 Therapeutics A/S?
Our model estimates a bankruptcy risk of 3.0% over the next 12 months (high risk), which is 2.1 times the average for Danish companies.
Who is the CEO of MC2 Therapeutics A/S?
Trine Ahlgreen is the CEO of MC2 Therapeutics A/S.
Who is the auditor of MC2 Therapeutics A/S?
MC2 Therapeutics A/S most recently used Cedra Godkendt Revisionsaktieselskab.
When was MC2 Therapeutics A/S founded?
MC2 Therapeutics A/S was founded on 4 May 2006.
What is the equity of MC2 Therapeutics A/S?
Equity was DKK -224.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.